Analyst Research

Report Title Price
Provider: New Constructs, LLC
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Angiodynamics Inc Announces Management Changes


Monday, 19 Nov 2012 04:08pm EST 

Angiodynamics Inc announced that Executive Vice President and Chief Financial Officer Joseph Gersuk will retire from the Company on January 31, 2013. He will be succeeded by Mark T. Frost, who was recently Chief Financial Officer and Senior Vice President of Administration of Albany Molecular Research Inc. 

Company Quote

14.55
0.24 +1.68%
29 Jul 2014